JG
IMGN

Jefferies Group’s Immunogen Inc IMGN Stock Holding History

Jefferies Group’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-200,340
Closed -$1.14M – 2087
2021
Q3 		$1.14M Buy
+200,340
New +$1.16M 0.01% 948
2019
Q2 		– Sell
-20,300
Closed -$55K – 2944
2019
Q1 		$55K Buy
+20,300
New +$87.9K ﹤0.01% 2193
2015
Q3 		– Sell
-705
Closed -$10K – 3200
2015
Q2 		$10K Sell
705
-84,209
-99% -$925K ﹤0.01% 2829
2015
Q1 		$760K Sell
84,914
-88,427
-51% -$641K ﹤0.01% 1186
2014
Q4 		$1.06M Buy
+173,341
New +$1.59M 0.01% 954
2014
Q3 		– Sell
-103
Closed -$1K – 2520
2014
Q2 		$1K Buy
+103
New +$1.29K ﹤0.01% 2023
2013
Q4 		– Sell
-21,900
Closed -$373K – 2277
2013
Q3 		$373K Buy
+21,900
New +$385K ﹤0.01% 1334

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jefferies Group's IMGN Position: Q4 2021 in Review

Jefferies Group sold out of Immunogen Inc (IMGN) in Q4 2021, closing a stake of 200,340 shares — an estimated $1.14M sold.

Jefferies Group first reported a position in IMGN in Q3 2013 and held it in 7 quarters. The position peaked at $1.14M in Q3 2021. 236 funds tracked by Wall St. Rank hold IMGN as of Q4 2021.

  • Jefferies Group reported no remaining Immunogen Inc position as of Q4 2021 after selling out during the quarter.
  • Jefferies Group sold 200,340 Immunogen Inc shares in Q4 2021, an estimated $1.14M.
  • Jefferies Group first reported a position in Immunogen Inc in Q3 2013 and held it in 7 quarters.
  • Jefferies Group's Immunogen Inc position peaked at $1.14M in Q3 2021.
  • 236 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2021.

Based on Jefferies Group's 13F filing for Q4 2021, filed 14 Feb 2022.